Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis

详细信息    查看全文

• 作者：Rachel D. Kramer ; BS^a ; ^{rdkramer@med.umich.edu} ; Mary A.M. Rogers ; PhD^b ; ^c ; Marisa Conte ; MLIS^d ; Jason Mann ; MSA^b ; Sanjay Saint ; MD ; MPH^b ; ^c ; Vineet Chopra ; MD ; MSc^b ; ^c
• 关键词：Antimicrobial-coated ; Central venous access ; Infection prevention
• 刊名：American Journal of Infection Control
• 出版年：2017
• 出版时间：1 February 2017
• 年：2017
• 卷：45
• 期：2
• 页码：108-114
• 全文大小：884 K
• 卷排序：45

文摘

Antimicrobial peripherally inserted central catheters (PICCs) may reduce the risk of central line-associated bloodstream infection (CLABSI). However, data regarding efficacy are limited. We aimed to evaluate whether antimicrobial PICCs are associated with CLABSI reduction.MethodsMEDLINE, EMBASE, CINHAL, and Web of Science were searched from inception to July 2016; conference proceedings were searched to identify additional studies. Study selection and data extraction were performed independently by 2 authors.ResultsOf 597 citations identified, 8 studies involving 12,879 patients met eligibility criteria. Studies included adult and pediatric patients from intensive care, long-term care, and general ward settings. The incidence of CLABSI in patients with antimicrobial PICCs was 0.2% (95% confidence interval [CI], 0.0%-0.5%), and the incidence among nonantimicrobial catheters was 5.3% (95% CI, 2.6%-8.8%). Compared with noncoated PICCs, antimicrobial PICCs were associated with a significant reduction in CLABSI (relative risk [RR], 0.29; 95% CI, 0.10-0.78). Statistical heterogeneity (I2, 71.6%; T2 = 1.07) was resolved by publication type, with peer-reviewed articles showing greater reduction in CLABSI (RR, 0.21; 95% CI, 0.06-0.74). Twenty-six patients (95% CI, 21-75) need to be treated with antimicrobial PICCs to prevent 1 CLABSI. Studies of adults at greater baseline risk of CLABSI experienced greater reduction in CLABSI (RR, 0.20; P = .003).ConclusionsAvailable evidence suggests that antimicrobial PICCs may reduce CLABSI, especially in high-risk subgroups. Randomized trials are needed to assess efficacy across patient populations.